Literature DB >> 3045692

Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.

M Rodriguez1, L I Truh, B P O'Neill, V A Lennon.   

Abstract

Sera from three of four patients with paraneoplastic cerebellar degeneration (PCD) associated with gynecologic cancer had antibodies that stained the cytoplasm of Purkinje cells in a characteristic discrete and coarsely granular pattern. No such antibodies were found in PCD patients with small cell cancer of the lung, in patients with cerebellar degeneration without cancer, in nonneurologic patients with small cell carcinoma or gynecologic cancer, or in normal subjects. Immunoelectron microscopy revealed that the antibodies of PCD bound to clusters of ribosomes, granular endoplasmic reticulum, and the trans-face of the vesicles of the Golgi complex in Purkinje cells. Immunostaining was localized in orderly arrays of stacked parallel cisternae of the endoplasmic reticulum in the perikaryon and dendritic processes. This pattern suggested that at least one autoantigen of PCD may be a glycoprotein specific cerebellar tissue that is associated with the endoplasmic reticulum. Some patches of Purkinje plasma membrane also were immunostained.

Entities:  

Mesh:

Year:  1988        PMID: 3045692     DOI: 10.1212/wnl.38.9.1380

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Anti-Purkinje cell cytoplasmic and neuronal nuclear antibodies aid diagnosis of paraneoplastic autoimmune neurological disorders.

Authors:  V A Lennon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

2.  Paraneoplastic cerebellar degeneration associated with multiple myeloma--3.4 years follow up.

Authors:  S Akpinar; O Berk; L Karaca
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

3.  Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.

Authors:  John E Greenlee; Susan A Clawson; Kenneth E Hill; Blair L Wood; Ikuo Tsunoda; Noel G Carlson
Journal:  J Neuropathol Exp Neurol       Date:  2010-10       Impact factor: 3.685

4.  Human autoantibodies against desmoplakins in paraneoplastic pemphigus.

Authors:  J R Oursler; R S Labib; L Ariss-Abdo; T Burke; E J O'Keefe; G J Anhalt
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells.

Authors:  H Tomimoto; J M Brengman; T Yanagihara
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Circulating antineuronal antibodies reach neurons in vivo: an autopsy study.

Authors:  M Drlicek; U Liszka; K Jellinger; A Mohn-Staudner; F Lintner; W Grisold
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

7.  Paraneoplastic encephalo-myelo-ganglionitis: cellular binding sites of the antineuronal antibody.

Authors:  M Yamada; A Inaba; M Yamawaki; K Ishida; T Yokota; T Uchihara; Y Eishi; R Okeda
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption.

Authors:  J E Greenlee; J B Burns; J W Rose; K A Jaeckle; S Clawson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Anti-purkinje cell and natural autoantibodies in a group of psychiatric patients. Evidences for a correlation with the psychopathological status.

Authors:  Roberto Delle Chiaie; Brunella Caronti; Francesco Macrì; Sandra Campi; Marzia Marino; Alessandra Corrado; Maria Caredda; Massimo Biondi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-08-23

Review 10.  Paraneoplastic neurological syndrome: an evolving story.

Authors:  Jiraporn Jitprapaikulsan; Pritikanta Paul; Smathorn Thakolwiboon; Shivam Om Mittal; Sean J Pittock; Divyanshu Dubey
Journal:  Neurooncol Pract       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.